Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

CLL

Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance

Abstract

Some cellular and molecular features of chronic lymphocytic leukaemia (CLL) cells that are associated with prognosis may reflect the context within which their progenitors encountered antigen. It follows that the nature of antigen drive in CLL could influence the clinical course and we were prompted to assess the impact, if any, of affinity maturation (an antigen-driven process) on prognosis. Statistical models for assessing affinity maturation status are typically applied to VH gene sequence data analysed using a web-based resource like IMGT or VBASE. Since these resources differ with respect to some key relevant features, we evaluated a cohort of CLL cases by applying statistical models to VH data derived from both IMGT and VBASE. Important differences between the resulting data sets became apparent. These resulted from database variance and because IMGT and VBASE define complementarity-determining and framework regions (CDRs, FRs) in different ways. Thus, the numbers of mutations identified and their distribution between CDRs/FRs varied between the data sets for the majority of clones. Consequently, two different but overlapping sets of cases with evidence of affinity maturation were defined. Notwithstanding their differences, no significant associations of affinity maturation status with CD38 expression, p53 functional status or survival were identifiable in either data set.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Rozman C, Montserrat E . Chronic lymphocytic leukaemia. N Engl J Med 1995; 333: 1052–1057.

    Article  CAS  Google Scholar 

  2. Caligaris-Capio F, Hamblin TJ . B-cell chronic lymphocytic leukaemia: a bird of a different feather. J Clin Oncol 1999; 17: 399–408.

    Article  Google Scholar 

  3. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR . Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukaemia. Blood 2002; 100: 1404–1409.

    Article  CAS  Google Scholar 

  4. Matrai Z, Lin K, Dennis M, Sherrington P, Zuzel M, Pettitt AR et al. CD38 expression and IgVH gene mutation in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 1902.

    Article  CAS  Google Scholar 

  5. Damle RN, Wasil T, Fais F . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.

    CAS  PubMed  Google Scholar 

  6. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98: 181–186.

    Article  CAS  Google Scholar 

  7. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854.

    CAS  PubMed  Google Scholar 

  8. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.

    CAS  PubMed  Google Scholar 

  9. Neuberger MS, Ehrenstein MR, Rada C, Sale J, Batista FD, Williams G et al. Memory in the B-cell compartment: antibody affinity maturation. Philos Trans R Soc London B 2000; 355: 357–360.

    Article  CAS  Google Scholar 

  10. Schroder AE, Greiner A, Seyfert C, Berek C . Differentiation of B cells in the nonlymphoid tissue of the synovial membrane in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1996; 93: 221–225.

    Article  CAS  Google Scholar 

  11. Matsumoto M, Lo SF, Carruthers CJL, Min J, Mariathasan S, Huang G et al. Affinity maturation without germinal centres in lymphotoxin-α-deficient mice. Nature 1996; 382: 462–466.

    Article  CAS  Google Scholar 

  12. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515–1525.

    Article  CAS  Google Scholar 

  13. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to iummunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647.

    Article  CAS  Google Scholar 

  14. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad Jr J, Miljkovic V et al. Transcriptional analysis of the B cell germinal centre reaction. Proc Natl Acad Sci USA 2003; 100: 2639–2644.

    Article  CAS  Google Scholar 

  15. Damle RN, Ghiotto F, Valetto A, Albesiano E, Fais F, Yan XJ et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002; 99: 4087–4093.

    Article  CAS  Google Scholar 

  16. Chiorazzi N, Ferrarini M . B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003; 21: 841–894.

    Article  CAS  Google Scholar 

  17. Chang B, Casali P . The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994; 15: 367–373.

    Article  CAS  Google Scholar 

  18. Wagner SD, Neuberger MS . Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 1996; 14: 441–457.

    Article  CAS  Google Scholar 

  19. Keppler TB . Codon bias and plasticity in immunoglobulins. Mol Biol Evol 1997; 14: 637–643.

    Article  Google Scholar 

  20. Lossos IS, Tibshirani R, Narasimhan B, Levy R . The inference of antigen selection on Ig genes. J Immunol 2000; 165: 5122–5126.

    Article  CAS  Google Scholar 

  21. Dörner T, Brezinschek H-P, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE . Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol 1997; 158: 2779–2789.

    PubMed  Google Scholar 

  22. Dyer MJS, Oscier DG . The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 2002; 16: 973–984.

    Article  CAS  Google Scholar 

  23. Lefranc M-P . IMGT, the international ImMunoGeneTics database®. Nucleic Acids Res 2003; 31: 307–310.

    Article  CAS  Google Scholar 

  24. Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD et al. Structural repertoire of the human VH segments. J Mol Biol 1992; 227: 799–817.

    Article  CAS  Google Scholar 

  25. Tomlinson IM, Cox JP, Gherardi E, Lesk AM, Chothia C . The structural repertoire of the human Vκ . EMBO J 1995; 14: 4628–4638.

    Article  CAS  Google Scholar 

  26. Williams SC, Frippiat J-P, Tomlinson IM, Ignatovich O, Lefranc M-P, Winter G . Sequence and evolution of the human germline Vλ repertoire. J Mol Biol 1996; 264: 220–232.

    Article  CAS  Google Scholar 

  27. Kabat E, Wu T, Reid-Miller M, Perry H, Gottesman K . Sequences of Proteins of Immunological Interest, Public Health Service National Institutes of Health, US Department of Health and Human Services 1991. Bethesda Maryland, USA.

    Google Scholar 

  28. Lefranc M-P . The IMGT unique numbering for immunoglobulins, T cell receptors and Ig-like domains. Immunologist 1999; 7: 132–136.

    CAS  Google Scholar 

  29. Lin K, Manocha S, Harris RJ, Matrai Z, Sherrington PD, Pettitt AR . High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3–21 gene segment. Blood 2003; 102: 1145–1146.

    Article  CAS  Google Scholar 

  30. Davis ZA, Orchard JA, Corcoran MM, Oscier DG . Divergence from the germ-line sequence in unmutated chronic lymphocytic leukemia is due to somatic mutation rather than polymorphisms. Blood 2003; 102: 3075.

    Article  CAS  Google Scholar 

  31. Forconi F, Sahota SS, Lauria F, Stevenson FK . Revisiting the definition of somatic mutational status in B-cell tumors: does 98% homology mean that a VH-gene is mutated? Leukemia 2004; 18: 882–883.

    Article  CAS  Google Scholar 

  32. Hans-Helmar A, Werner M (http://www.dnaplot.de).

  33. Pettitt AR, Sherrington PD, Stewart G, Cawley JC, Taylor AM, Stankovic T . p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 2001; 98: 814–822.

    Article  CAS  Google Scholar 

  34. Messmer BT, Albesiano E, Messmer D, Chiorazzi N . The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004; 103: 3490–3495.

    Article  CAS  Google Scholar 

  35. Kröber A, Benner A, Bühler A, Döhner H, Stilgenbauer S . Multivariate survival analysis of specific VH-genes in CLL: V3–21 and V3–23 are prognostic factors independently of the VH mutation status. Blood 2002; 100: 738.

    Google Scholar 

  36. Degan M, Bomben R, Dal Bo M, Zucchetto A, Nanni P, Rupolo M et al. Analysis of IgVH gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol 2004; 126: 29–42.

    Article  CAS  Google Scholar 

  37. Pettitt AR, Sherrington PD, Allsup DJ, Matrai Z, Cawley JC, Zuzel M . Natural history of chronic lymphocytic leukaemia: current thinking. In: Hamblin T, Johnson S, Miles A (eds). The Effective Management of Chronic Lymphocytic Leukaemia. UK Key Advances in Clinical Practice Series 2004. Aesculapius Medical Press, London, UK.

    Google Scholar 

  38. Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P et al. V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416.

    PubMed  Google Scholar 

  39. Adams CL, Macleod MKL, Milner-White EJ, Aitken R, Garside P, Stott DI . Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology 2003; 108: 274–287.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P D Sherrington.

Additional information

This work was supported by the UK Leukaemia Research Fund and the Royal Liverpool and Broadgreen Hospitals Trust R&D Fund

Supplementary Information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lane, B., Mensah, A., Lin, K. et al. Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance. Leukemia 19, 741–749 (2005). https://doi.org/10.1038/sj.leu.2403720

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403720

Keywords

This article is cited by

Search

Quick links